Penicillium marneffeiInfection in AIDS
Author(s) -
Stephenie Y. N. Wong,
K. F. Wong
Publication year - 2011
Publication title -
pathology research international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.398
H-Index - 21
eISSN - 2090-8091
pISSN - 2042-003X
DOI - 10.4061/2011/764293
Subject(s) - penicillium marneffei , dimorphic fungus , medicine , antifungal , gold standard (test) , human immunodeficiency virus (hiv) , antiretroviral treatment , antifungal drugs , intensive care medicine , fungal pathogen , antiretroviral therapy , antifungal drug , opportunistic infection , pathogen , immunology , dermatology , biology , viral disease , coinfection , viral load , genetics , yeast
Penicillium marneffei is a dimorphic fungus which is endemic in Southeast Asia. It is an opportunistic pathogen which has emerged to become an AIDS-defining illness in the endemic areas. Early diagnosis with prompt initiation of treatment is crucial for its management. Prompt diagnosis can often be established through careful cytological and histological examination of clinical specimens although microbiological culture remains the gold standard for its diagnosis. Standard antifungal treatment for AIDS patients with penicilliosis is well established. Highly active antiretroviral therapy should be started early together with the antifungal treatment. Special attention should be paid to potential drug interaction between antiretroviral and antifungal treatments. Secondary prophylaxis may be discontinued with a low risk of relapse of the infection once the immune dysfunction has improved.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom